Achieving Stoma-Free After Intersphincteric Resection Remains a Long and Challenging Journey [0.03%]
经肛门间骶肌切除术后无造口仍任重而道远
Songtao Bai,Bo Liu,Song Zhao
Songtao Bai
Yu Zhang,Yihu Mao,Lie Yang
Yu Zhang
What Every Colon Rectal Surgeon Should Know About the Centers for Medicare & Medicaid Services Transforming Episode Accountability Model (TEAM) Initiative [0.03%]
结直肠外科医师应了解的关于医疗保险和医疗补助服务中心转型期责任模型（TEAM）计划的内容
Vitaliy Poylin,John Tillou,Don B Colvin;ASCRS Healthcare Economics Committee
Vitaliy Poylin
Postoperative Recurrence in Crohn's Disease: The Ongoing Challenge of Risk Stratification [0.03%]
克罗恩病术后复发：风险分层的持续挑战
İbrahim Ethem Güven
İbrahim Ethem Güven
Clinical Practice Guideline for the Surgical Management of Ulcerative Colitis [0.03%]
溃疡性结肠炎外科治疗临床实践指南
Amy L Lightner,Ira Leeds,Michael F McGee et al.
Amy L Lightner et al.
Alexander Rpkm van Renterghem,Adrianus M van der Holst,Sander Mj van Kuijk et al.
Alexander Rpkm van Renterghem et al.
Jiahao Zhou,Qingbin Wu,Ziqiang Wang
Jiahao Zhou
Comment on "Neoadjuvant Chemotherapy Versus Chemoradiation for Locally Advanced Rectal Cancer: A Multicenter Propensity Score-Matched Study" [0.03%]
关于“局部晚期直肠癌新辅助化疗与化学放射治疗的多中心倾向性匹配研究”的点评
Obafemi K Wuraola,Constantine Ezeme,Pratik Bhattacharya et al.
Obafemi K Wuraola et al.
Short-Course Radiation Integrated With Immunochemotherapy Gives a Higher Pathological Complete Response Compared With the Long-Course Chemoradiation With Chemotherapy in the Total Neoadjuvant Therapy for Local Advanced Rectal Carcinoma in the Real World: a Retrospective Study [0.03%]
短疗程放疗联合免疫化疗对比长疗程化放疗在局晚直肠癌全程新辅助治疗中的病理完全缓解率：一项回顾性研究
Chang Su,Yugui Lian,Xiangbo Wan et al.
Chang Su et al.
Background: Total neoadjuvant therapy is the recommended modality for patients with locally advanced rectal carcinoma and those whose lesions are less than 5 centimeters from the anal verge. The optimal integration of tot...